GILD Gilead Sciences, Inc. logo

GILD Gilead Sciences, Inc.

Healthcare
$133.73-0.47%ClosedMarket Cap: $166.04B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

2,258

13F Shares

1,089,857,322

Ownership %

87.7%

New Positions

319

Increased Positions

1187

Closed Positions

148

Reduced Positions

738

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
BBHVanEck Biotech ETF390,09214.72%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF3,356,18214.67%
VETS3,356,18214.67%
SLTPacer Salt High truBeta US Market ETF3,356,18214.67%
VIRS3,356,18214.67%
LSLTPacer Salt Low truBeta US Market ETF3,356,18214.67%
IBBQInvesco Nasdaq Biotechnology ETF40,6297.92%
IBBiShares Biotechnology ETF4,515,7077.91%
AFTYPacer CSOP FTSE China A50 ETF799,0906.50%
BIBProShares - Ultra Nasdaq Biotechnology30,9055.68%
PJPInvesco Pharmaceuticals ETF144,3695.08%
PBEInvesco Biotechnology & Genome ETF87,2644.97%
WBIE45,9944.88%
WBIY46,9934.79%
PBPHPortfolio Building Block World Pharma and Biotech Index ETF227,4164.44%
GLUXGreat Lakes Aviation, Ltd.139,0424.42%
BAMDBrookstone Dividend Stock ETF27,2873.94%
DHSD LN43,2913.73%
PINKSimplify Health Care ETF62,0113.73%
SIXHETC 6 Meridian Hedged Equity Index Option ETF165,0713.66%